Results 31 to 40 of about 4,265 (97)

Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study.

PLoS ONE, 2019
ObjectivesTo elucidate the effect of cinacalcet use on all-cause and cause-specific hospitalization outcomes using a prospective cohort of maintenance hemodialysis patients.MethodsWe used data from a prospective cohort of Japanese hemodialysis patients ...
Shinji Asada, Kazuki Yoshida, Shingo Fukuma, Takanobu Nomura, Michihito Wada, Yoshihiro Onishi, Noriaki Kurita, Masafumi Fukagawa, Shunichi Fukuhara, Tadao Akizawa   +9 more
doaj   +1 more source

Meta-analysis of cinacalcet plus calcitriol for the treatment of secondary hyperparathyroidism in hemodialysis patients

Linchuang shenzangbing zazhi, 2022
ObjectiveTo evaluate the efficacy and adverse reactions of cinacalcet plus calcitriol in the treatment of secondary hyperparathyroidism in hemodialysis patients.MethodsClinical trial of cinacalcet plus calcitriol in the treatment of secondary ...
Feng Hui-ling, Zhang Lian, Zhang Jin-ming, Wu Xiao-yan   +3 more
doaj  

Uso de cinacalcet para el control del hiperparatiroidismo en pacientes con diferentes grados de insuficiencia renal

Nefrología, 2016
Antecedentes: Los efectos de cinacalcet en el hiperparatiroidismo secundario (HPTS), persistente o asociado a hipercalcemia han sido descritos en pacientes en diálisis.
José M. Orellana, Rafael J. Esteban, Yina A. Castilla, Rafael Fernández-Castillo, Gonzalo Nozal-Fernández, María A. Esteban, María García-Valverde, Juan Bravo   +7 more
doaj   +1 more source

Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism

International Journal of Nephrology and Renovascular Disease, 2013
Kazunori Nakayama,1,2 Kazushi Nakao,1,2 Yuji Takatori,1,2 Junko Inoue,1 Shoichirou Kojo,1 Shigeru Akagi,1,2 Masaki Fukushima,2 Jun Wada,1 Hirofumi Makino11Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine ...
Nakayama K, Nakao K, Takatori Y, Inoue J, Kojo S, Akagi S, Fukushima M, Wada J, Makino H   +8 more
doaj  

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism

International Journal of Endocrinology, 2010
Background. Management of multiple-endocrine neoplasia type 1- (MEN1-) associated hyperparathyroidism is associated with high recurrence rates and high surgical morbidity due to multiple neck explorations.
V. J. Moyes, J. P. Monson, S. L. Chew, S. A. Akker   +3 more
doaj   +1 more source

Comparative efficacy of sodium thiosulfate, bisphosphonates, and cinacalcet for the treatment of vascular calcification in patients with haemodialysis: a systematic review and network meta-analysis

BMC Nephrology
Background Up to now, there is no unequivocal intervention to mitigate vascular calcification (VC) in patients with hemodialysis. This network meta-analysis aimed to systematically evaluate the clinical efficacy of sodium thiosulfate, bisphosphonates ...
Lei He, Yuzhe Li, Jingjing Jin, Meijuan Cheng, Yaling Bai, Jinsheng Xu   +5 more
doaj   +1 more source

Three-Year Successful Cinacalcet Treatment of Secondary Hyperparathyroidism in a Patient with X-Linked Dominant Hypophosphatemic Rickets: A Case Report

Case Reports in Endocrinology, 2014
Hypophosphatemic rickets (HR) is a rare inherited disorder characterized by a classic rickets phenotype with low plasma phosphate levels and resistance to treatment with vitamin D.
Diana Grove-Laugesen, Lars Rejnmark
doaj   +1 more source

The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report

BMC Nephrology, 2017
Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving chronic dialysis therapy. Although cinacalcet can control parathyroid function and bone turnover, preventing ectopic calcification remains challenging ...
Daisuke Takada, Tatsuo Tsukamoto, Miho Fuse, Shinpei Kada, Motoko Yanagita   +4 more
doaj   +1 more source

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients

Drug Design, Development and Therapy, 2016
Sohyun Jeong,1 In-Wha Kim,1 Kook-Hwan Oh,2 Nayoung Han,1 Kwon Wook Joo,2 Hyo Jin Kim,2 Jung Mi Oh1 1College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, 2Department of Internal Medicine, Division of ...
Jeong S, Kim IW, Oh KH, Han N, Joo KW, Kim HJ, Oh JM   +6 more
doaj  

Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor

Archives of Endocrinology and Metabolism, 2017
SUMMARY Neuroendocrine tumors (NETs) can secrete hormones, including ectopic secretions, but they have been rarely associated with malignant hypercalcemia. A 52-year-old man with a history of diabetes mellitus was diagnosed with a pancreatic tumor.
Hernan Valdes-Socin, Matilde Rubio Almanza, Mariana Tomé Fernández-Ladreda, Daniel Van Daele, Marc Polus, Marcela Chavez, Albert Beckers   +6 more
doaj   +1 more source